Nuvectis Pharma, Inc. Quarterly General and Administrative Expense in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Nuvectis Pharma, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q1 2021 to Q3 2024.
  • Nuvectis Pharma, Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $1.54M, a 7.9% decline year-over-year.
  • Nuvectis Pharma, Inc. General and Administrative Expense for the twelve months ending September 30, 2024 was $7.58M, a 3.84% increase year-over-year.
  • Nuvectis Pharma, Inc. annual General and Administrative Expense for 2023 was $7.52M, a 25.1% increase from 2022.
  • Nuvectis Pharma, Inc. annual General and Administrative Expense for 2022 was $6.01M, a 79.4% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.58M $1.54M -$132K -7.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $7.71M $1.7M +$190K +12.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $7.52M $1.74M +$2K +0.12% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $7.52M $2.6M +$220K +9.24% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $7.3M $1.67M +$254K +17.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $7.04M $1.51M +$442K +41.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $6.6M $1.73M +$594K +52.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $6.01M $2.38M +$1.26M +112% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $4.75M $1.42M +$906K +177% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $3.84M $1.07M -$625K -36.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.47M $1.14M +$1.12M +4857% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $3.35M $1.12M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $512K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.69M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $23K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.